Diabetes drugs are being used to treat obesity, but are they safe?
Novo Nordisk's insulin pen receives EU approval to treat type 2 diabetes
Sempre Health and Novo Nordisk to partner to lower diabetes drug cost - Pharmaceutical Technology
Diabetes and You | Diabetes Education for Patients | novoMEDLINK™
Novo Nordisk - Wikipedia
Abbott and Novo Nordisk to offer integrated solution for diabetes
European regulator investigates Ozempic, Wegovy maker on thyroid cancer risk
With growing popularity of new weight loss drugs, doctors emphasize potential risks - ABC News
Greater China: sales of Novo Nordisk's key antidiabetic drugs 2021 | Statista
Ozempic and Mounjaro are mostly back on tap in the US: FDA | Fierce Pharma
Diabetes Treatments | Novo Nordisk U.S.
Novo Nordisk to launch two medications for diabetes, weight loss in 2022
Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)
FDA Approves Ozempic, A Powerful Once-Weekly Type 2 Diabetes Medication
Novo Nordisk 2018: Struggling against the tide – PharmaLive
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
Novo Nordisk: Pick Up This Diabetes Leader In 2018 (NYSE:NVO) | Seeking Alpha
Novo Nordisk to slash insulin drug for diabetes price by up to 75% | The Independent
Ozempic, Wegovy maker begins legal proceedings against certain med spas, clinics, compounding pharmacies - Local News 8
Diabetesmedikament: EMA warnt vor Nebenwirkungen bei Diabetes-Präparaten von Novo Nordisk
Warnung vor Diabetes-Präparaten : EMA berichtet von schwerwiegenden Nebenwirkungen des Wirkstoffes Semaglutid
Greater China: net sales of Novo Nordisk's antidiabetic drugs by type 2021 | Statista
Insulin costs: Novo Nordisk joins Eli Lilly in reducing prices of diabetes medication | PhillyVoice
Tell us about your experiences of weight-loss medication | Health | The Guardian
FDA nod for Rybelsus label update
